Helpful articles on wellness, nutrition and everyday support for your body.
Проект INCUS готовит спутники с радарами и микроволновыми датчиками, чтобы глубже изучать, как из тепла и влажности рождаются тропические штормы. Чем точнее наука описывает их механизмы, тем надежнее могут становиться прогнозы и оценка рисков.
Researchers have uncovered how bacteria coordinate enzymes to build families of closely related anti-cancer compounds. The findings may help scientists design new HDAC-inhibitor therapies faster and more precisely.
Vitamin B12 is needed in tiny amounts, but its deficiency can affect energy, nerves, and cognition. Because symptoms can creep in slowly, low B12 is sometimes mistaken for normal aging.
Creatine is best known for athletic performance, but new lab research suggests it may also support immune defenses—especially the cells that help start an anti-cancer response. The evidence is early and based mainly on experiments, so it’s not a substitute for cancer treatment.
New research suggests intermittent fasting and continuous calorie restriction may lead to comparable weight loss, but people often experience very different day-to-day mental effort. For some, fasting windows reduce the need for constant calorie tracking and willpower.
Wenn Eltern im Alltag häufig auf das Handy schauen, kann das bei Kindern das Gefühl von Unwichtigkeit und fehlender Verlässlichkeit verstärken. Studien zeigen Zusammenhänge zwischen dieser „digitalen Abwesenheit“ und unsicheren Bindungsmustern.
A small study found that smelling dark or milk chocolate before a workout may change how many repetitions people can do. Here’s what this could mean for “beauty from within” routines—and where the evidence is still limited.
Исследователи из Университета Питтсбурга показали, что одной мутации теломеразы (TERT) для «бессмертия» меланомы недостаточно. Важную роль играет белок TPP1, который усиливает поддержание длины теломер.
Orforglipron, a daily oral pill studied in people with type 2 diabetes, showed stronger improvements in blood sugar and weight outcomes than existing oral semaglutide options in a 52-week trial. At the same time, gastrointestinal side effects were reported more often.
